Sort
10,829 grants matching “car t”
Circadian molecular regulation of the xenobiotic response
$415,425Katja A Lamia · Scripps Research Institute, The · R01 · FY2015 · DK
Enhancing CAR-T cell therapy through theranostic targeted radionuclide therapy
$415,260Yanping Yang · Methodist Hospital Research Institute · R21 · FY2024 · CA
Targeting metabolic stress response to improve CAR-T cell efficacy.
$415,257Irene M. Min · Methodist Hospital Research Institute · R21 · FY2024 · CA
Harnessing B Cells after Stem Cell Transplant to Produce Novel CAR-Ts
$415,257Stefanie Sarantopoulos · Duke University · R21 · FY2025 · CA
NSF-AoF: CNS Core: Small: Reinforcement Learning for Real-time Wireless Scheduling and Edge Caching: Theory and Algorithm Design
$415,000Junshan Zhang · University Of California-Davis · · FY2021 · CSE
NSF-AoF: CNS Core: Small: Reinforcement Learning for Real-time Wireless Scheduling and Edge Caching: Theory and Algorithm Design
$415,000Junshan Zhang · Arizona State University · · FY2021 · CSE
REU Site: CAT Vehicle: The Cognitive and Autonomous Test Vehicle
$415,000Loukas Lazos · University Of Arizona · · FY2020 · CSE
SupplyChainDCL: Enhancing Resilience, Optimizing Efficiency, and Mitigating Disruption Risks in Supply Chain Networks
$414,909Agostino Capponi · Columbia University · · FY2024 · ENG
Anticipatory Affect and Financial Risk Taking
$414,723Brian D Knutson · Stanford University · · FY2008 · SBE
SBIR Phase II: High Performance Supercapacitors Based on Nano-engineered Electrodes
$414,690Jae Ryu · Agiltron Incorporated · · FY2011 · TIP
RI: Medium: Collaborative Research: Novel microLIDAR Design and Sensing Algorithms for Flapping-Wing Micro-Aerial Vehicles
$414,477Sanjeev Koppal · University Of Florida · · FY2015 · CSE
Development of Frequency Modulation Coherent Anti-Stokes Raman Scattering Microscopy
$414,468Xiaoliang S Xie · Harvard University · · FY2007 · BIO
Role of Cell Integrins in Adenoviral Conjunctivitis
$414,461Glen R. Nemerow · Scripps Research Institute, The · R01 · FY2009 · EY
Adoptive Therapy of Ovarian Cancer with Autologous Genetically Modified T Cells
$414,354Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA
Maximizing Visual Potential in Age-Related Macular Degeneration
$414,209Preeti Verghese · Smith-Kettlewell Eye Research Institute · R01 · FY2017 · EY
A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children
$414,188Yin Wang · University Of Maryland Baltimore · R01 · FY2021 · CA
Investigating a Novel Inhibitory Receptor in Regulating CAR-T Cell Persistence and Function
$413,971Li Lily Wang · Cleveland Clinic Lerner Com-Cwru · R21 · FY2024 · CA
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
$413,953Song Li · University Of California Los Angeles · R01 · FY2021 · CA
Novel synthetic receptors with improved antigen specificity and specificity for cancer therapy
$413,943Stanley R Riddell · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Synthetic epigenetic circuits: tunable cell fate switches controlled by dynamic and combinatorial inputs
$413,916Wendell A Lim · University Of California, San Francisco · R01 · FY2021 · CA
Convoys of Care: Developing Collaborative Care Partnerships in Assisted Living
$413,775Candace Lynn Kemp · Georgia State University · R01 · FY2013 · AG
Controlling HIV latency by manipulating CycT1 turnover
$413,735Koh Fujinaga · University Of California, San Francisco · R01 · FY2022 · AI
Regulation of Zbtb44-Eomes complex in CD8+T cells and anti-tumor immunity
$413,727Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2022 · AI
Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.
$413,715Daniel Abate-Daga · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Membrane Transporters: Critical Determinants For Aids Antiviral Drugs
$413,707David Miller · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES